ViewRay, Inc. (VRAYQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (-90.00%)
Sep 9, 2025, 12:01 PM EDT
ViewRay Market Cap
ViewRay has a market cap or net worth of $1.83 thousand as of September 9, 2025. Its market cap has decreased by -90.00% in one year.
Market Cap
1.83K
Enterprise Value
n/a
Revenue
105.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 10, 2015, ViewRay's market cap has decreased from 188.28M to 1.83K, a decrease of -100.00%. That is a compound annual growth rate of -68.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 1.83K | 902.19% |
| Dec 31, 2024 | 183.00 | - |
| Dec 29, 2023 | 183.00 | -100.00% |
| Dec 30, 2022 | 812.74M | -16.61% |
| Dec 31, 2021 | 974.62M | 71.81% |
| Dec 31, 2020 | 567.27M | -4.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 780.18M |
| Elite Pharmaceuticals | 742.62M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 345.48M |